Merck conundrum, page-55

  1. 204 Posts.
    lightbulb Created with Sketch. 120
    Thoughts originally posted on “that dumpster fire other site”

    $IMMP I think it really comes down to Immutep’s ability to find a development partner. They’ve taken a long time to get to this point independently, and efti reaching its full potential requires deep pockets and expertise. Hopefully 90mg efti with Paclitaxol data creates a deal along with the efti + Keytruda data to date. Safety concerns for TACTI-004 regarded a triple combination, not the dual like we see in AIPAC-003. I don’t think it would have fully enrolled with severe AE’s. 90mg+Paclitaxol fully enrolled. Patients and families win, we win.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
25.0¢
Change
0.005(2.04%)
Mkt cap ! $365.0M
Open High Low Value Volume
25.0¢ 25.3¢ 24.5¢ $620.5K 2.512M

Buyers (Bids)

No. Vol. Price($)
6 66277 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 22044 3
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.